Introduction to HyQvia Administration Systems
HyQvia is indicated for the treatment of primary immunodeficiency (PI) and chronic inflammatory demyelinating polyneuropathy (CIDP). This guide helps healthcare professionals select appropriate equipment for infusing HyQvia.
Identifying the Patient’s Administration System
Patients may require different administration systems based on their treatment indication (PI or CIDP). This guide provides considerations for selecting a peristaltic pump, syringe driver pump, and ancillary devices.
Important Safety Information
HyQvia carries warnings and precautions for thrombosis, hypersensitivity, immunogenicity, and other potential risks. Please see the full prescribing information for complete details.
Manual:
Download: HyQvia Administration Systems Guide
Chat: Powered By VoiceSphere